• HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
Saturday, February 27, 2021
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
  • HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Dr. James Martin Elected to the 2021 Class of the National Academy of Inventors

Bioengineer by Bioengineer
February 12, 2021
in Health
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Texas Heart Institute Cardiomyocyte Renewal Lab Director Honored by NAI

IMAGE

Credit: Texas Heart Institute

The Texas Heart Institute is pleased to announce that Dr. James Martin, Director of its Cardiomyocyte Renewal Lab, is one of 61 distinguished academic inventors to be elected to the 2021 class of NAI Senior Members at The National Academy of Inventors (NAI).

NAI Senior Members are active faculty, scientists, and administrators from NAI member institutions who have demonstrated remarkable innovation – producing technologies that have brought, or aspire to bring, real impact to the welfare of society – in a number of different disciplines. NAI Senior Members also have proven success in the areas of patenting, licensing, and commercialization.

The ability to nominate an individual for NAI Senior Member recognition is an exclusive opportunity afforded solely to NAI member institutions in order to recognize their outstanding innovators. These multi-faceted organizations are widely regarded as innovation powerhouses that continuously promote and foster the spirit of innovation.

“Dr. Martin has long been a steward of scientific advancement and has proven to be a tremendous asset to the Texas Heart Institute and to its Cardiomyocyte Renewal Lab through his efforts to translate fundamental biological discoveries in cardiac development and disease into novel treatment strategies for cardiac regeneration,” noted Dr. Darren Woodside, Vice President for Research at Texas Heart Institute. He added, “Everyone at the Texas Heart Institute is thrilled for Dr. Martin, whose induction into the NAI as a Senior Member is well-deserved.”

In his years as a researcher, Dr. James Martin has authored more than 170 peer-reviewed papers in top journals such as Nature, Science, Cell, Developmental Cell, Plos Genetics, Development, and PNAS (H-index 79). He discovered that Hippo signaling is a critical repressor of adult heart regeneration, and his recent groundbreaking work on the Hippo pathway in heart size regulation has generated landmark studies that have led to the insight that the Hippo pathway is an endogenous inhibitor of adult heart muscle regeneration. His insights have revealed new avenues for the treatment of human heart failure. He holds 9 U.S. patents and applications, including one provisional application, all of which have been licensed to Yap Therapeutics, a company he co-founded. His research has been and is currently supported by multiple federal granting agencies, including multiple NIH NHLBI R01 and DOD grants.

As Director of Texas Heart Institute’s Cardiomyocyte Renewal Lab, Dr. Martin leads a department that focuses on understanding how genetic pathways are connected to adult tissue homeostasis and regeneration. By obtaining an in-depth understanding of these pathways, the team hopes to develop treatments and techniques that will prevent disorders like heart failure and atrial fibrillation and develop new treatments to treat heart disease.

This latest class of NAI Senior Members represents 36 research universities, government, and non-profit research institutes. They are named inventors on over 617 issued U.S. patents.

“NAI Member Institutions support some of the most elite innovators on the horizon. With the NAI Senior Member award distinction, we are recognizing innovators who are rising stars in their fields and the innovative ecosystems that support their work,” said Paul R. Sanberg, NAI President. “This new class is joining a prolific group of academic visionaries already defining tomorrow.”

Following a nomination for NAI Senior Member, individuals undergo a rigorous selection process by the NAI Advisory Committee, which is composed of elected NAI members and other professionals who are considered pioneers in their respective fields.

Senior Members are elected biannually, and nominations are accepted on a rolling basis. Nominations are currently being accepted for the next Senior Member class.

A full list of NAI Senior Members is available on the NAI website.

###

ABOUT TEXAS HEART INSTITUTE (THI)

The Texas Heart Institute, founded by world-renowned cardiovascular surgeon Dr. Denton A. Cooley in 1962, is a nonprofit organization dedicated to reducing the devastating toll of cardiovascular disease through innovative and progressive programs in research, education, and improved patient care. THI’s scientists and physicians conduct fundamental biomedical, translational, and clinical research in cardiology, cardiovascular surgery, molecular-based medicine, stem cell and gene therapy, and regenerative medicine both independently and in collaboration with organizations worldwide. As global leaders of patient care for nearly six decades, Texas Heart Institute has been ranked among the top cardiovascular centers in the United States by U.S. News & World Report for the past 30 years. THI is dedicated to spreading awareness and sharing updates on ways to prevent, treat and defeat cardiovascular disease. With over 10 million visitors coming to its website from around the world every year, http://www.texasheart.org is just one of the ways THI is helping to educate people on the importance of heart health. For more information, please visit https://www.texasheart.org.

About the National Academy of Inventors (NAI)

The National Academy of Inventors is a member organization comprising U.S. and international universities, and governmental and non-profit research institutes, with over 4,000 individual inventor members and Fellows spanning more than 250 institutions worldwide. It was founded in 2010 to recognize and encourage inventors with patents issued from the U.S. Patent and Trademark Office, enhance the visibility of academic technology and innovation, encourage the disclosure of intellectual property, educate and mentor innovative students, and translate the inventions of its members to benefit society. The NAI publishes the multidisciplinary journal, Technology, and Innovation. For more information, please visit http://www.academyofinventors.org

Media Contact
Keri Sprung
[email protected]

Original Source

https://www.texasheart.org/dr-james-martin-director-of-the-cardiomyocyte-renewal-lab-at-texas-heart-institute-elected-to-the-2021-class-of-the-national-academy-of-inventors/

Tags: Medicine/Health
Share12Tweet8Share2ShareShareShare2

Related Posts

IMAGE

UTA researcher explores effects of trauma at the cellular, tissue levels of the brain

February 26, 2021
IMAGE

Picture books can boost physical activity for youth with autism

February 26, 2021

Oahu marine protected areas offer limited protection of coral reef herbivorous fishes

February 26, 2021

Sensing robot healthcare helpers being developed at SFU

February 26, 2021

Leave a Reply Cancel reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

POPULAR NEWS

  • IMAGE

    Terahertz accelerates beyond 5G towards 6G

    638 shares
    Share 255 Tweet 160
  • People living with HIV face premature heart disease and barriers to care

    82 shares
    Share 33 Tweet 21
  • Global analysis suggests COVID-19 is seasonal

    38 shares
    Share 15 Tweet 10
  • HIV: an innovative therapeutic breakthrough to optimize the immune system

    35 shares
    Share 14 Tweet 9

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Tags

Technology/Engineering/Computer ScienceMedicine/HealthcancerInfectious/Emerging DiseasesEcology/EnvironmentMaterialsCell BiologyClimate ChangeBiologyGeneticsPublic HealthChemistry/Physics/Materials Sciences

Recent Posts

  • Predicts the onset of Alzheimer’s Disease (AD) using deep learning-based Splice-AI
  • When foams collapse (and when they don’t)
  • UTA researcher explores effects of trauma at the cellular, tissue levels of the brain
  • Picture books can boost physical activity for youth with autism
  • Contact Us

© 2019 Bioengineer.org - Biotechnology news by Science Magazine - Scienmag.

No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

© 2019 Bioengineer.org - Biotechnology news by Science Magazine - Scienmag.

Welcome Back!

Login to your account below

Forgotten Password?

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In